• Users Online: 8
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2019  |  Volume : 6  |  Issue : 3  |  Page : 132-135

A pilot study of fear of disease consequences and its relationship with quality of life, depression and anxiety in patients with multiple sclerosis


1 Tabriz Health Services Management Research Center, Health Management and Safety Promotion Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
2 Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
3 Students' Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
4 Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran
5 Ardabil Azad University, Ardabil, Iran
6 Department of Health Services Management, Iranian Center of Excellence in Health Management, Tabriz University of Medical Sciences, Tabriz, Iran

Correspondence Address:
Dr. Naser Derakhshani
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/iahs.iahs_9_19

Get Permissions

Aims: This study aims to determine the relationship between fear of disease consequences and its relationship with quality of life, symptoms of depression, and anxiety in patients with multiple sclerosis (MS). Materials and Methods: This cross-sectional study was conducted at Tabriz University of Medical Sciences. Seventy patients suffering from MS were selected using the convinced sampling method. Data collection tools were included: Fear of Progression Questionnaire-Short Form, World Health Organizations Quality of Life-Brief, Beck Depression Inventory, and Beck Anxiety Inventory. Descriptive statistical methods, independent sample t-test, one-way ANOVA, Spearman's correlation coefficient test, and linear regression model were used to analyze data by SPSS.22 software. Results: In this study, 38 (54.3%) of patients were male. Mean score of fear of the disease, quality of life, depression, and anxiety was 28.68 ± 9.18, 86.47 ± 14.11, 15.22 ± 4.86, and 15.85 ± 5.55, respectively. Results of Spearman's test indicated a significant relationship between fear of disease consequences on the one hand and quality of life (rs= −0.53), symptoms of depression (rs= −0.52), and anxiety (rs= −0.48) on the other hand (P < 0.001). Results of linear regression analysis demonstrated that there is a strength correlation between depression – as the predictive variable – and quality of life (P = 0.018, standard error [SE] = 0.793, β = −0.283 R2 = 0.57), and anxiety – as the predictive variable – and quality of life (P = 0.005, SE = 0.681, β = 0.332 R2 = 0.64). Conclusion: Considering negative effects of fear of the disease consequences on quality of life, symptoms of depression and anxiety, the patients should be informed about their own conditions, and appropriate mental and health cares should be provided, and effective interventions should be done to alleviate the fear of the patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed181    
    Printed4    
    Emailed0    
    PDF Downloaded60    
    Comments [Add]    

Recommend this journal